title: [Oral contraception: evolution of concepts over the last thirty years].
authors.forename: J
authors.initials: J
authors.lastname: Belaisch
authors.forename: B
authors.initials: B
authors.lastname: Hommais-loufrani
mesh_terms: D001157:Arterial Occlusive Diseases; D001290:Attitude; D001519:Behavior; D002319:Cardiovascular System; D002560:Cerebrovascular Circulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003695:Delivery of Health Care; D003710:Demography; D019049:Developed Countries; D004194:Disease; D004467:Economics; D005060:Europe; D005193:Family Planning Services; D005602:France; D006262:Health; D006282:Health Personnel; D010820:Physicians; D011153:Population; D011157:Population Dynamics; D045167:Progesterone Congeners; D011584:Psychology; D012106:Research; D013672:Technology; D013995:Time; D013997:Time Factors; D014652:Vascular Diseases; D014680:Veins
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D045167:Progesterone Congeners
keywords: Arterial Occlusive Diseases; Attitude; Behavior; Cardiovascular Effects; Cerebrovascular Effects; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--changes; Contraceptive Methods--complications; Contraceptive Methods--side effects; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Economic Factors; Europe; Family Planning; France; Health; Health Personnel; Longterm Effects; Mediterranean Countries; Oral Contraceptives, Combined--complications; Oral Contraceptives, Low-dose; Oral Contraceptives, Phasic; Oral Contraceptives--changes; Oral Contraceptives--side effects; Physicians; Population; Population Dynamics; Progestins, Low-dose; Psychological Factors; Research And Development; Research Methodology; Technology; Time Factors; Vascular Diseases; Venous Engorgement; Western Europe